Company Filing History:
Years Active: 2010
Title: Innovator Mark Derek Cregan: A Pioneer in Cellular Isolation Methods
Introduction: Mark Derek Cregan, an inventive mind based in Clarkson, Australia, has made significant contributions to the field of biotechnology. With one patented invention to his name, Cregan's work encapsulates the intricate relationship between human biology and innovative medical applications.
Latest Patents: Cregan's noteworthy patent, titled "Method for isolating cells from mammary secretion," focuses on the innovative isolation of progenitor cells from human mammary secretions. This method highlights the extraction of pluripotent or multipotent progenitor cells that could be derived from colostrum, mature milk, or specific secretions. The invention is particularly significant during various physiological periods, such as non-pregnant, pregnant, lactating, and involuting phases. The implications of such isolated cells possess potential uses in regenerative medicine and therapeutic applications.
Career Highlights: Currently, Mark Cregan is associated with Carag Ag, a company devoted to advancing biotechnological solutions. His work there emphasizes not only the pursuit of innovative methods for cellular isolation but also expands the possibilities for medical research and treatment options.
Collaborations: Cregan collaborates with his colleague Peter Hartmann, sharing insights and expertise to further refine their research initiatives. Their collective efforts aim to enhance the fields of biotechnology and regenerative medicine through innovative approaches.
Conclusion: Mark Derek Cregan stands out as an influential inventor in the realm of biotechnology with his patented method for isolating progenitor cells. His contributions at Carag Ag reflect a commitment to exploring new frontiers in medical science, promising advancements that could reshape our understanding and treatment of human health conditions.